Fund BasicsSee More
- Fund Family REX Shares
- Assets Under Management 4,574,400
- Shares Outstanding, K 30
- 60-Month Beta 6.02
- Price/Earnings ttm 22.80
- Annual Dividend & Yield N/A
- Most Recent Dividend N/A
- Management Fee 0.95%
|Period||Period Low||Period High||Performance|
| || |
+87.53 (+105.02%)since 02/05/21
| || |
+98.96 (+137.60%)since 12/04/20
| || |
-191.62 (-52.86%)since 03/05/20
Renewed optimism over speedy economic recovery from the pandemic-driven recession kept the bullish run intact.
We highlight six best-performing leveraged equity ETFs that piled up more than 50% gains through midway Q1.
Last week was quite a lull for Wall Street. A jump in U.S. treasury yields can be held responsible for the broader market underperformance.
Last week was marked by the bitcoin rally, some Reddit bets and an uptrend in some cyclical sectors.
Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden's administration have renewed the appeal for the riskier assets last week.
The S&P 500, the Nasdaq-100 and the Dow Jones gained about 3.6%, 5.9% and 3.4%, respectively, last week.
The S&P 500, the Dow Jones and the Nasdaq Composite gained about 1.7%, 1.0% and 2.1%, respectively, last week.
The solid fundamentals and a soaring stock market have resulted in huge demand for the leveraged ETFs.
Last week was all about vaccine hopes and a stupendous Wall Street rally.
Wall Street spiked on Nov 9 on news that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
|3rd Resistance Point||197.64|
|2nd Resistance Point||185.60|
|1st Resistance Point||178.24|
|1st Support Level||158.84|
|2nd Support Level||146.79|
|3rd Support Level||139.43|